FDA Approves New Coronavirus Vaccine "Mixed Fighting" Enhanced Vaccination Program

Today, the U.

The FDA's "mixed" enhanced vaccination authorization is based on clinical trial data provided by the National Institute of Allergy and Infectious Diseases (NIAID), expert committee recommendations, and FDA's analysis of existing data

The FDA also cited examples of “mixed” vaccination in the statement.

In addition, people who are vaccinated with Moderna or Pfizer/BioNTech's new crown vaccine can receive a single dose of Moderna (dose halved), Pfizer/BioNTech, or Johnson's new crown vaccine as an enhanced vaccination after at least 6 months after completing the two injections

The authorization for Moderna's new crown vaccine allows a single dose of Moderna booster vaccine (dose halved) in people who have completed two doses of vaccination for at least 6 months

The authorization for Johnson & Johnson's new crown vaccine allows a single dose of Johnson & Johnson's booster vaccine to be given to adults over the age of 18 who have completed a single dose of vaccination for at least 2 months

With the concerted efforts of the global biomedical industry, a variety of safe and effective vaccines have been developed at a record speed, providing an important tool for protecting public health

Reference materials:

[1] Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines.